
Jennifer A. Woymach, MD, provides background information on the AO41702 study, which evaluates targeted therapy ibrutinib or ibrutinib plus rituximab in elderly patients with previously untreated chronic lymphocytic leukemia.<br />

Your AI-Trained Oncology Knowledge Connection!


Published: January 16th 2020 | Updated: